« Holiday Blogging |
| A Mystery Chemistry Glassware Kit »
December 23, 2013
Merry Christmas From the FDA
I see that the FDA is in the holiday spirit - they've told Ariad that they can bring Iclusig back to the market in the US, subject to restrictions, and Amarin, who have been trying, quite unsuccessfully, to get approval for wide use of a fish-oil-pill, have at least gotten a stay of execution for now. And in what is a real surprise, United Therapeutics got approval for an oral version of treprostinil, a synthetic prostaglandin analog, for PAH. Since they'd been turned down twice before on that one, I don't think anyone anticipated that one, since it hadn't looked too impressive in the clinic.
+ TrackBacks (0) | Category: Regulatory Affairs
POST A COMMENT
- RELATED ENTRIES
- How Not to Do It: NMR Magnets
- Allergan Escapes Valeant
- Vytorin Actually Works
- Fatalities at DuPont
- The New York TImes on Drug Discovery
- How Are Things at Princeton?
- Phage-Derived Catalysts
- Our Most Snorted-At Papers This Month. . .